| MolName | 2-[(2E)-2-(5-chlorothiophen-2-yl)sulfonylimino-3-cyclohexyl-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide |
| MolecularFormula | C21H22N3O4ClS3 |
| Smiles | O=C(CC(C(N1C2CCCCC2)=O)S/C1=N/S(c(s1)ccc1Cl)(=O)=O)Nc1ccccc1 |
| InChI | InChI=1S/C21H22ClN3O4S3/c22-17-11-12-19(31-17)32(28,29)24-21-25(15-9-5-2-6-10-15)20(27)16(30-21)13-18(26)23-14-7-3-1-4-8-14/h1,3-4,7-8,11-12,15-16H,2,5-6,9-10,13H2,(H,23,26)/t16-/m1/s1 |
| InChIK | WROLBUYWDYGOSB-MRXNPFEDSA-N |
| TotalMolweight | 512.074 |
| Molweight | 512.074 |
| MonoisotopicMass | 511.046094 |
| CLogP | 4.6996 |
| CLogS | -5.733 |
| H Acceptors | 7 |
| H Donors | 1 |
| TotalSurfaceArea | 351.24 |
| Relative PSA | 0.33889 |
| PolarSurfaceArea | 157.83 |
| Druglikeness | -0.80587 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.5 |
| Fragments | 1 |
| Non HAtoms | 32 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| StereoCenters | 1 |
| Rotatable Bond | 5 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 11 |
| Sp3Atoms | 10 |
| Symmetricatoms | 5 |
| Amides | 2 |
| StereoCon | racemate |
Click to Load Molecule:
1 - 2-[(2E)-2-(5-chlorothiophen-2-yl)sulfonylimino-3-cyclohexyl-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide | 2 - 2-[(2E)-2-(5-chlorothiophen-2-yl)sulfonylimino-3-cyclohexyl-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide